These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19935498)

  • 1. The comorbidity of diabetes mellitus and psychiatric disorders.
    Medved V; Jovanović N; Knapić VP
    Psychiatr Danub; 2009 Dec; 21(4):585-8. PubMed ID: 19935498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychofarmacology in the prevention of somatic comorbid diseases in mentally ill patients.
    Jukić V; Petrović Z; Brecić P; Krizaj A; Savić A; Baceković A; Bilić P; Susac J; Mandić A; Prazen I
    Psychiatr Danub; 2009 Sep; 21(3):350-5. PubMed ID: 19794355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization.
    Masand PS; Culpepper L; Henderson D; Lee S; Littrell K; Newcomer JW; Rasgon N
    CNS Spectr; 2005 Oct; 10(10):suppl14 1-15. PubMed ID: 16404802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight gain in the treatment of mood disorders.
    Aronne LJ; Segal KR
    J Clin Psychiatry; 2003; 64 Suppl 8():22-9. PubMed ID: 12892538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
    Citrome LL; Holt RI; Zachry WM; Clewell JD; Orth PA; Karagianis JL; Hoffmann VP
    Ann Pharmacother; 2007 Oct; 41(10):1593-603. PubMed ID: 17785613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic medications: metabolic and cardiovascular risk.
    Newcomer JW
    J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
    Jerrell JM; McIntyre RS; Tripathi A
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up.
    Medved V; Kuzman MR; Jovanovic N; Grubisin J; Kuzman T
    J Psychopharmacol; 2009 Nov; 23(8):915-22. PubMed ID: 18635691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schizophrenia and diabetes mellitus: not an improbable combination].
    Cohen D; Gispen-de Wied CC
    Ned Tijdschr Geneeskd; 2003 May; 147(21):993-6. PubMed ID: 12811967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of schizophrenia with obesity, metabolic, and endocrinological disorders.
    Monteleone P; Martiadis V; Maj M
    Psychiatr Clin North Am; 2009 Dec; 32(4):775-94. PubMed ID: 19944883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and schizophrenia 2005: are we any closer to understanding the link?
    Holt RI; Bushe C; Citrome L
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):56-65. PubMed ID: 16280338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes mellitus after treatment with clozapine].
    Brugman NJ; Cohen D; de Vries RH
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):437-9. PubMed ID: 10719549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implications of weight changes with antipsychotic treatment.
    Sussman N
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.